Company research
Natera, Inc.
CIK 1604821Updated Nov 18, 2026
NTRA price & chart
Loading TradingView…
NASDAQ:NTRA on TradingView ↗About the company
Natera™ is a global leader in cell-free DNA and precision medicine, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 400 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, San Carlos, California, and Boulder, Colorado. For more information, visit www.natera.com.
In the news
No coverage from other publishers is available.
Seeking Alpha
Diagnostic stocks safe from proposed crackdown on Medicare fraud ↗
Natera, Inc. (NTRA) Presents at 2026 UBS Global Healthcare Conference Transcript ↗
SEC disclosures
Natera, Inc. files 8-K: Material Event ↗
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 1,821,482,000Source | 1,590,947,000Source | 2,657,497,000Source | 1,757,066,000Source | 1,516,989,000Source | 2,614,398,000Source | 1,732,366,000Source | 1,468,205,000Source | 2,398,344,000Source | 1,660,735,000Source | 1,441,699,000Source | 1,394,474,000Source |
| Property, Plant and Equipment, NetUSD | 206,496,000Source | 142,170,000Source | 317,568,000Source | 189,224,000Source | 133,280,000Source | 269,379,000Source | 180,453,000Source | 125,791,000Source | 241,184,000Source | 162,046,000Source | 111,210,000Source | 92,453,000Source |
| GoodwillUSD | — | — | 141,100,000Source | — | — | 140,857,000Source | — | — | 141,070,000Source | — | — | — |
| Intangible Assets, Net (Excluding Goodwill)USD | — | — | 360,204,000Source | — | — | 367,362,000Source | — | — | 373,713,000Source | — | — | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | — | — | — | — | — | — | — | — | — | — | 466,005,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 286,379,000Source | 306,876,000Source | 421,968,000Source | 309,224,000Source | 335,936,000Source | 417,595,000Source | 318,233,000Source | 288,748,000Source | 296,528,000Source | 314,165,000Source | 278,289,000Source | 244,385,000Source |
| Inventory, NetUSD | 64,644,000Source | 48,724,000Source | 80,346,000Source | 54,272,000Source | 40,985,000Source | 70,721,000Source | 50,367,000Source | 43,024,000Source | 68,443,000Source | 44,744,000Source | 40,759,000Source | 35,406,000Source |
| Assets, CurrentUSD | 1,447,323,000Source | 1,322,565,000Source | 1,658,950,000Source | 1,431,596,000Source | 1,301,816,000Source | 1,651,813,000Source | 1,416,385,000Source | 1,261,444,000Source | 1,496,939,000Source | 1,375,820,000Source | 1,258,549,000Source | 1,211,817,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 53,862,000Source | 44,631,000Source | 65,134,000Source | 52,104,000Source | 37,798,000Source | 75,565,000Source | 56,185,000Source | 46,734,000Source | 55,828,000Source | 48,635,000Source | 60,524,000Source | 33,634,000Source |
| Operating Lease, Right-of-Use AssetUSD | 96,988,000Source | 87,856,000Source | 129,687,000Source | 95,128,000Source | 52,582,000Source | 133,987,000Source | 94,631,000Source | 54,553,000Source | 108,541,000Source | 86,149,000Source | 56,537,000Source | 71,874,000Source |
| Other Assets, NoncurrentUSD | 70,675,000Source | 38,356,000Source | 49,988,000Source | 41,118,000Source | 29,311,000Source | 51,000,000Source | 40,897,000Source | 26,417,000Source | 36,897,000Source | 36,720,000Source | 15,403,000Source | 18,330,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 569,294,000Source | 712,422,000Source | 835,998,000Source | 510,884,000Source | 680,469,000Source | 840,380,000Source | 492,691,000Source | 674,094,000Source | 685,931,000Source | 465,315,000Source | 676,372,000Source | 688,730,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 14,000Source | 12,000Source | 14,000Source | 14,000Source | 12,000Source | 14,000Source | 14,000Source | 12,000Source | 14,000Source | 12,000Source | 11,000Source | 11,000Source |
| Retained Earnings (Accumulated Deficit)USD | -2,823,280,000Source | -2,514,091,000Source | -2,928,082,000Source | -2,735,736,000Source | -2,482,499,000Source | -2,861,113,000Source | -2,634,798,000Source | -2,445,035,000Source | -2,776,022,000Source | -2,567,862,000Source | -2,377,436,000Source | -1,942,635,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -187,000Source | -765,000Source | -108,000Source | -287,000Source | -1,358,000Source | -202,000Source | -197,000Source | -2,192,000Source | -258,000Source | -344,000Source | -3,085,000Source | -16,362,000Source |
| Stockholders' Equity Attributable to ParentUSD | 1,252,188,000Source | 878,525,000Source | 1,821,499,000Source | 1,246,182,000Source | 836,520,000Source | 1,774,018,000Source | 1,239,675,000Source | 794,111,000Source | 1,712,413,000Source | 1,195,420,000Source | 765,327,000Source | 705,744,000Source |
| Additional Paid in Capital, Common StockUSD | 4,075,641,000Source | 3,393,369,000Source | 4,749,675,000Source | 3,982,191,000Source | 3,320,365,000Source | 4,635,319,000Source | 3,874,656,000Source | 3,241,326,000Source | 4,488,679,000Source | 3,763,614,000Source | 3,145,837,000Source | 2,664,730,000Source |
| Liabilities and EquityUSD | 1,821,482,000Source | 1,590,947,000Source | 2,657,497,000Source | 1,757,066,000Source | 1,516,989,000Source | 2,614,398,000Source | 1,732,366,000Source | 1,468,205,000Source | 2,398,344,000Source | 1,660,735,000Source | 1,441,699,000Source | 1,394,474,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 442,016,000Source | 301,416,000Source | 553,200,000Source | 384,836,000Source | 314,574,000Source | 558,257,000Source | 365,677,000Source | 305,949,000Source | 441,228,000Source | 344,045,000Source | 307,274,000Source | 310,499,000Source |
| Operating Lease, Liability, CurrentUSD | 14,006,000Source | 9,762,000Source | 15,123,000Source | 13,056,000Source | 12,384,000Source | 14,823,000Source | 12,199,000Source | 11,957,000Source | 15,581,000Source | 10,168,000Source | 11,621,000Source | 7,639,000Source |
| Accounts Payable, CurrentUSD | 46,499,000Source | 27,834,000Source | 75,154,000Source | 36,879,000Source | 33,100,000Source | 62,397,000Source | 39,240,000Source | 26,038,000Source | 33,156,000Source | 34,922,000Source | 14,998,000Source | 31,148,000Source |
| Operating Lease, Liability, NoncurrentUSD | 104,380,000Source | 98,953,000Source | 143,074,000Source | 102,741,000Source | 61,225,000Source | 144,953,000Source | 103,056,000Source | 64,160,000Source | 118,473,000Source | 96,588,000Source | 67,025,000Source | 76,577,000Source |
| Other Liabilities, NoncurrentUSD | — | — | 25,262,000Source | — | — | 16,266,000Source | — | — | 11,687,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 701,000Source | 25,669,000Source | 15,426,000Source | 20,078,000Source |
| Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | 282,945,000Source | 281,653,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -85,091,000Source | -66,936,000Source | -208,160,000Source | -190,426,000Source | -434,801,000Source | -547,799,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 14,517,000Source | 9,237,000Source | 41,764,000Source | 30,968,000Source | 24,097,000Source | 16,702,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 95,107,000Source | 77,827,000Source | 354,404,000Source | 274,428,000Source | 191,808,000Source | 152,384,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 121,067,000Source | 4,068,000Source | -20,752,000Source | 35,876,000Source | 33,904,000Source | 124,081,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 2,278,000Source | 5,623,000Source | 20,871,000Source | 3,985,000Source | 5,353,000Source | 8,257,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 21,880,000Source | 2,379,000Source | 753,000Source | 13,210,000Source | -15,458,000Source | 5,462,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 40,171,000Source | 44,452,000Source | 215,301,000Source | 135,664,000Source | -246,955,000Source | -431,501,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | 16,021,000Source | — | — | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -32,137,000Source | -16,815,000Source | -132,209,000Source | 137,624,000Source | 168,498,000Source | 330,338,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 22,137,000Source | 21,815,000Source | 106,188,000Source | 66,423,000Source | 39,199,000Source | 47,697,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 3,758,000Source | 544,000Source | 47,461,000Source | 30,204,000Source | 254,461,000Source | 482,640,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 1,041,438,000Source | 892,844,000Source | 1,091,502,000Source | 1,000,021,000Source | 1,087,932,000Source | 973,768,000Source | 1,076,140,000Source | 945,587,000Source | 642,095,000Source | 466,091,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 889,000Source | 1,005,000Source | 4,069,000Source | 7,897,000Source | 11,346,000Source | 8,060,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 499,000Source | 1,307,000Source | 295,000Source | 549,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 90,637,000Source | 70,644,000Source | 103,097,000Source | 93,358,000Source | 95,107,000Source | 77,827,000Source | 354,404,000Source | 274,428,000Source | — | — |
| Amortization of Intangible AssetsUSD | — | — | — | — | 5,700,000Source | 0Source | 7,100,000Source | 300,000Source | 3,900,000Source | — | — | — |
| DepreciationUSD | — | — | — | — | 13,100,000Source | 8,900,000Source | 12,600,000Source | 8,200,000Source | 36,500,000Source | 27,200,000Source | 22,700,000Source | 16,700,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | — | — | — | -258,000Source | -138,000Source | -17,000Source | -462,000Source | -265,000Source | — |
| Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | — | — | — | — | -906,000Source |
| GoodwillUSD | — | — | — | — | 141,100,000Source | — | 140,857,000Source | — | 141,070,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | — | — | 207,000Source | 730,000Source | -261,000Source | 275,000Source | 283,000Source | 173,000Source | -59,929,000Source | 695,000Source | 271,000Source | 978,000Source |
| Inventory Write-downUSD | — | — | — | — | — | — | — | — | — | 454,000Source | 2,175,000Source | 200,000Source |
| Marketable Securities, Unrealized Gain (Loss)USD | — | — | — | — | — | — | — | — | — | — | — | 2,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -87,544,000Source | -31,592,000Source | -66,969,000Source | -100,938,000Source | -85,091,000Source | -66,936,000Source | -208,160,000Source | -190,426,000Source | -434,801,000Source | -547,799,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | — | -547,799,000Source |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | — | — | — | — | — | — | 0Source | 5,000,000Source | 23,000,000Source | 314,400,000Source | 306,000,000Source | 216,500,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 3,863,000Source | 544,000Source | 22,536,000Source | 12,988,000Source | 3,892,000Source | 6,411,000Source |
| Realized Investment Gains (Losses)USD | — | — | — | — | — | — | — | — | — | — | — | 900,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Goodwill, Impairment Loss | — | — | — | — | —Source | — | — | — | — | — | — | — |
| InterestExpenseNonoperating | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
| Other Nonoperating Income (Expense) | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
| Provision for Loan, Lease, and Other Losses | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 592,183,000Source | 439,758,000Source | 752,750,000Source | 546,600,000Source | 696,644,000Source | 501,830,000Source | 2,306,113,000Source | 1,696,911,000Source | 1,082,571,000Source | 820,222,000Source |
| Selling, General and Administrative ExpenseUSD | — | — | 308,546,000Source | 214,154,000Source | 327,203,000Source | 310,549,000Source | 327,938,000Source | 266,864,000Source | 1,177,261,000Source | 841,314,000Source | 618,307,000Source | 588,591,000Source |
| Operating Income (Loss)USD | — | — | -97,576,000Source | -39,338,000Source | -75,792,000Source | -110,372,000Source | -93,516,000Source | -79,177,000Source | -309,911,000Source | -222,294,000Source | -446,245,000Source | -541,040,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -87,337,000Source | -30,862,000Source | -67,230,000Source | -100,663,000Source | -84,808,000Source | -66,763,000Source | -268,089,000Source | -189,731,000Source | -434,530,000Source | -546,821,000Source |
| Income Tax Expense (Benefit)USD | — | — | 207,000Source | 730,000Source | -261,000Source | 275,000Source | 283,000Source | 173,000Source | -59,929,000Source | 695,000Source | 271,000Source | 978,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -87,544,000Source | -31,592,000Source | -66,969,000Source | -100,938,000Source | -85,091,000Source | -66,936,000Source | -208,160,000Source | -190,426,000Source | -434,801,000Source | -547,799,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.64Source | -0.26Source | -0.47Source | -0.74Source | -0.6Source | -0.5Source | -1.52Source | -1.53Source | -3.78Source | -5.57Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.64Source | -0.26Source | -0.47Source | -0.74Source | -0.6Source | -0.5Source | -1.52Source | -1.53Source | -3.78Source | -5.57Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 137,187,000Source | 123,775,000Source | 143,279,000Source | 136,388,000Source | 141,502,000Source | 134,750,000Source | 136,721,000Source | 124,718,000Source | 114,997,000Source | 98,408,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 137,187,000Source | 123,775,000Source | 143,279,000Source | 136,388,000Source | 141,502,000Source | 134,750,000Source | 136,721,000Source | 124,718,000Source | 114,997,000Source | 98,408,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | 5,700,000Source | 0Source | 7,100,000Source | 300,000Source | 3,900,000Source | — | — | — |
| Costs and ExpensesUSD | — | — | 689,759,000Source | 479,096,000Source | 828,542,000Source | 656,972,000Source | 790,160,000Source | 581,007,000Source | 2,616,024,000Source | 1,919,205,000Source | 1,528,816,000Source | 1,361,262,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | — | — | — | -258,000Source | -138,000Source | -17,000Source | -462,000Source | -265,000Source | — |
| Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | — | — | — | — | -906,000Source |
| Interest ExpenseUSD | — | — | 1,045,000Source | 3,142,000Source | — | 1,029,000Source | — | 1,005,000Source | 4,069,000Source | 10,685,000Source | 12,638,000Source | 9,319,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | 11,284,000Source | 11,618,000Source | — | 10,738,000Source | — | 13,419,000Source | 45,891,000Source | 43,248,000Source | 24,353,000Source | 3,538,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | — | -547,799,000Source |
| Realized Investment Gains (Losses)USD | — | — | — | — | — | — | — | — | — | — | — | 900,000Source |
| Research and Development ExpenseUSD | — | — | 173,412,000Source | 96,931,000Source | 228,071,000Source | 146,427,000Source | 210,702,000Source | 129,078,000Source | 624,110,000Source | 404,138,000Source | 320,678,000Source | 316,415,000Source |
| Other Nonoperating Income (Expense) | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
| Interest Expense (non-operating) | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
| Goodwill, Impairment Loss | — | — | — | — | —Source | — | — | — | — | — | — | — |
Offerings
Registration 333-299977
Filing attachments
tm2629516d1_ex99-1.htm · S-8 · 2026-11-12
Exhibit 99.1 Originally adopted March 7, 2022; amended and restated effective November 10, 2026 AMENDED AND RESTATED CHANGE OF CONTROL BONUS PLAN The Bonus Plan was originally adopted effective March 7, 2022, and Exhibit A was revised effective September 1, 2026. The Bonus Plan is hereby amended and restated effective November 10, 2026. This amendment and restatement is a continuation of, and not a new or replacement arrangement for, the Bonus Plan; does not alter any Participant’s Percentage…
Read attachment ↗ntra-20260930xex991.htm · 8-K · 2026-11-05
Exhibit 99.1 Natera Reports Third Quarter 2026 Financial Results AUSTIN, Texas, November 5, 2026 /BUSINESS WIRE/ - Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today reported its financial results for the third quarter ended September 30, 2026. Recent Financial Highlights • Generated total revenues of $794.0 million in the third quarter of 2026, compared to $592.2 million in the third quarter of 2025, an increase of 34.1%. • Generated a gross margin1…
Read attachment ↗ntra-20260930xex992.htm · 8-K · 2026-11-05
Natera, Inc. Q3’2026 Earnings Presentation November 5, 2026 2 Not for reproduction or further distribution. This presentation contains forward-looking statements under the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this presentation, including statements regarding our market opportunity, our anticipated products and launch schedules, our reimbursement coverage, our product costs and our gross margins, ou…
Read attachment ↗ntra-20260630xex991.htm · 8-K · 2026-08-06
EX-99.1 2 ntra-20260630xex991.htm EX-99.1 Document Exhibit 99.1 Natera Reports Second Quarter 2026 Financial Results AUSTIN, Texas, August 6, 2026 /BUSINESS WIRE/ - Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today reported its financial results for the second quarter ended June 30, 2026. Recent Financial Highlights • Generated total revenues of $752.8 million in the second quarter of 2026, compared to $546.6 million in the second quarter of 2025, …
Read attachment ↗ntra-20260630xex992.htm · 8-K · 2026-08-06
EX-99.2 3 ntra-20260630xex992.htm EX-99.2 ntra-20260630xex992 Natera, Inc. Q2’2026 Earnings Presentation August 6, 2026 2 Not for reproduction or further distribution. This presentation contains forward-looking statements under the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this presentation, including statements regarding our market opportunity, our anticipated products and launch schedules, our re…
Read attachment ↗ntra-20260331xex991.htm · 8-K · 2026-05-07
EX-99.1 2 ntra-20260331xex991.htm EX-99.1 Document Exhibit 99.1 Natera Reports First Quarter 2026 Financial Results AUSTIN, Texas, May 7, 2026 /BUSINESS WIRE/ - Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today reported its financial results for the first quarter ended March 31, 2026. Recent Financial Highlights • Generated total revenues of $696.6 million in the first quarter of 2026, compared to $501.8 million in the first quarter of 2025, an inc…
Read attachment ↗